5-(2-Chloro-phenyl)-2 H -pyrazole-3-carboxylic acid, 95.0%, 5g

2-(1H-Pyrazol-3-yl)aniline, 95.0%, 250mg

N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide, 97.0%, 5g

ethyl 1,3-thiazol-4-ylacetate, 95.0%, 100mg

N-(4-Hydroxy-3-methoxybenzyl)-8-methylnonanamide, 95.0%, 25mg

3-Oxoisoindoline-5-carboxylic acid, 95.0%, 1g

3-isopropylpiperidine, 95.0%, 5g

3-Bromo-4-chloro-6-ethoxyquinoline, 95.0%, 1g

4-Aminomethylbenzenesulfonamide hydrochloride, 95.0%, 25g

n-(2-Aminoethyl)morpholine-4-carboxamide oxalate, 97%, 25g

(4-((4-(2-Methoxyethyl)phenoxy)methyl)phenyl)boronic acid, 95.0%, 10g

(4-Bromopyridin-2-yl)methanol, 95.0%, 10g

Dialysis membrane Spectra/Por® Biotech CE MWCO 100,000, 24 mm, 1 Piece(s)